Ajmal Khan
Impact in
- Organic Chemistry top 0.5%
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
Papers in
- Pharmacology 66
- Cholinesterase and Neurodegenerative Diseases 33
- Pharmacological Effects of Medicinal Plants 24
-
- Synthesis and biological activity 56
- Synthesis and Characterization of Heterocyclic Compounds 20
- Co-authors
- Ahmed Al‐HarrasiSobia Ahsan HalimNajeeb Ur RehmanRené CsükJavid HussainAbdur RaufMumtaz AliM. Iqbal Choudhary
- Journals
- ACS Omega (19 papers)Bioorganic Chemistry (18 papers)Medicinal Chemistry Research (11 papers)RSC Advances (11 papers)International Journal of Biological Macromolecules (11 papers)
- Partner nations
- PakistanOmanSaudi Arabia
In The Last Decade
Ajmal Khan
312 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Organic Chemistry 2.0k
- Pharmacology 794
- Toxicology 135
- Pharmacology 327
- Endocrinology, Diabetes and Metabolism 617
Countries citing papers authored by Ajmal Khan
This map shows the geographic impact of Ajmal Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajmal Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajmal Khan more than expected).
Fields of papers citing papers by Ajmal Khan
This network shows the impact of papers produced by Ajmal Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajmal Khan. The network helps show where Ajmal Khan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ajmal Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 18 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 14 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 15 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 33 | |
| 19 | 2021 | 24 | |
| 20 | 2020 | 37 |
About Ajmal Khan
Ajmal Khan is a scholar working on Pharmacology, Organic Chemistry, Toxicology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 331 papers that have together received 5.1k indexed citations. Recurring topics across this work include Synthesis and biological activity (56 papers), Enzyme function and inhibition (49 papers), Natural Antidiabetic Agents Studies (42 papers), Computational Drug Discovery Methods (35 papers), Cholinesterase and Neurodegenerative Diseases (33 papers), Microbial Applications in Construction Materials (25 papers), Pharmacological Effects of Medicinal Plants (24 papers) and Synthesis and Characterization of Heterocyclic Compounds (20 papers). The work is most often cited by research in Organic Chemistry (2.0k citations), Pharmacology (794 citations), Toxicology (135 citations), Pharmacology (327 citations) and Endocrinology, Diabetes and Metabolism (617 citations). Ajmal Khan has collaborated with scholars based in Pakistan, Oman and Saudi Arabia. Frequent co-authors include Ahmed Al‐Harrasi, Sobia Ahsan Halim, Najeeb Ur Rehman, René Csük, Javid Hussain, Abdur Rauf, Mumtaz Ali, M. Iqbal Choudhary, Saeed Ullah and Abdul Latif. Their work appears in journals such as ACS Omega, Bioorganic Chemistry, Medicinal Chemistry Research, RSC Advances and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.